GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Santhera Pharmaceuticals Holding SANN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

15.20

+1.88%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Santhera Pharmaceuticals Holding — daily SIX:SANN End of day
Market value
CHF 173.1m
Last close × shares
Volume
43.7k
Shares, 9 Nov 2026

About Santhera Pharmaceuticals Holding

Its shares trade on SIX under the ticker SANN.SW. It has been listed since 3 November 2006. In the fiscal year to 31 December 2025, it reported revenue of CHF 77.2m and a net loss of CHF 49.2m. At that date it held total assets of CHF 148.1m and shareholders' equity of −CHF 11.8m.

Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. The company is headquartered in Pratteln, Basel-Landschaft. The company went IPO on 2006-11-03. The firm is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s products include Catena and Raxone brands, which are primarily implemented in the symptomatic treatment of Leber's Hereditary Optic Neuropathy (LHON) diseases. Sathera Pharmaceuticals Holding AG operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Figures and description from our data supplier, not checked against the company's own report.

More about Santhera Pharmaceuticals Holding →

Latest on Santhera Pharmaceuticals Holding

Our reporting

Next results

29 Apr 2027

Due on 29 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Santhera Pharmaceuticals Holding's ticker?

Santhera Pharmaceuticals Holding trades as SANN.SW on SIX, under ISIN CH1276028821.

What was Santhera Pharmaceuticals Holding's last closing price?

15.20 on 9 Nov 2026. The figure is in CHF and is never converted.

When does Santhera Pharmaceuticals Holding next report results?

Results are expected on 29 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.